Catalyst Wire Dossier Catalyst Wire Dossier

Jorveza

budesonide · Shire
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Jorveza, covering 2020-03-16 to 2026-04-15. Get the full timeline:

Most recent: EMA Authorised: Jorveza (Budesonide) — Dr. Falk Pharma GmbH

See pricing